KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Total Current Liabilities: 2020-2025

Historic Total Current Liabilities for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $115.3 million.

  • Ginkgo Bioworks Holdings' Total Current Liabilities rose 0.75% to $115.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.3 million, marking a year-over-year increase of 0.75%. This contributed to the annual value of $107.3 million for FY2024, which is 34.54% down from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Total Current Liabilities is $115.3 million, which was up 19.19% from $96.7 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Total Current Liabilities registered a high of $191.7 million during Q1 2023, and its lowest value of $1.4 million during Q1 2021.
  • Moreover, its 3-year median value for Total Current Liabilities was $163.3 million (2023), whereas its average is $142.9 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first spiked by 11,100.25% in 2022, then plummeted by 41.79% in 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Total Current Liabilities (Quarterly) stood at $134.8 million in 2021, then grew by 28.35% to $173.0 million in 2022, then dropped by 5.26% to $163.9 million in 2023, then tumbled by 34.54% to $107.3 million in 2024, then rose by 0.75% to $115.3 million in 2025.
  • Its last three reported values are $115.3 million in Q3 2025, $96.7 million for Q2 2025, and $115.7 million during Q1 2025.